SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-000740
Filing Date
2022-02-03
Accepted
2022-02-03 07:01:34
Documents
60
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20211231x10q.htm   iXBRL 10-Q 1270723
2 EX-31.1 tmb-20211231xex31d1.htm EX-31.1 7128
3 EX-31.2 tmb-20211231xex31d2.htm EX-31.2 7118
4 EX-32.1 tmb-20211231xex32d1.htm EX-32.1 9211
5 GRAPHIC tmb-20211231x10q001.jpg GRAPHIC 11917
  Complete submission text file 0001558370-22-000740.txt   4828545

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20211231.xsd EX-101.SCH 41363
7 EX-101.CAL tmb-20211231_cal.xml EX-101.CAL 33189
8 EX-101.DEF tmb-20211231_def.xml EX-101.DEF 105641
9 EX-101.LAB tmb-20211231_lab.xml EX-101.LAB 325762
10 EX-101.PRE tmb-20211231_pre.xml EX-101.PRE 238436
54 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20211231x10q_htm.xml XML 784035
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37410 | Film No.: 22586515
SIC: 2834 Pharmaceutical Preparations